Trades Actions Biotechs

Articles

Affichage des articles du juin, 2018

Bon week-end a toutes/tous

ACADIA Pharmaceuticals Announces FDA Approval of New Dosing Formulation and Strength for NUPLAZID® (Pimavanserin) | Business Wire

U.S. Dialysis Catheter Market Analysis & Outlook to 2024 - MedCore - ResearchAndMarkets.com | Business Wire

22nd Century宣布新的非转基因极低尼古丁烤烟和白肋烟变种 | Business Wire

PharmaCyte Biotech Discusses Importance of Shrinking Pancreatic Cancer Tumors in Latest Q

recommandations

Veritas Appoints Mr. Filios Theodorou as Its Agent for Cyprus and SEMEA Countries

Insulet Presents Positive Clinical Trial Results for the Omnipod® Horizon™ Hybrid Closed-Loop System at the American Diabetes Association's 78th Scientific Sessions | Business Wire

Dashboard - Meine Einschätzungen - sharewise.com

Medtronic Announces Second Bone Cement Solution Indicated for Treating Sacral Fractures

22nd Century Conducts Three Short-Term Studies in Support of the Company’s MRTP Application to the FDA | Business Wire

ＰＨＣホールディングス株式会社：薬剤師の業務効率化を目指した保険薬局用電子薬歴システム「PharnesV-MX」を販売開始 | Business Wire

Shire plc : Rule 2.9 Announcement

ITM: FDA Acceptance of IND to Advance Phase III Clinical Trial COMPETE with Solucin® for Treatment of GEP-NET in the U.S. | Business Wire

Insulet to Unveil New Omnipod® DASHTM System and Present Innovative Research at the American Diabetes Association's 78th Scientific Sessions | Business Wire

ObsEva's EDELWEISS Trial Hits All Goals In Endometriosis-associated Pain

ImmunoGen Announces FDA Fast Track Designation for Mirvetuximab Soravtansine in Patients with Platinum-Resistant Ovarian Cancer | Business Wire

BioTrace Medical Announces Key Events Featuring Tempo® Lead at TVT 2018 | Business Wire

Bonne fête des papas

Cerus Presents Results of European Phase 3 Chronic Anemia Study at the 23rd Congress of European Hematology Association | Business Wire

Global Healthcare Contract Research and Manufacturing Outsourcing Market to Post a CAGR of 12% | Technavio | Business Wire

DIAXONHIT DEVIENT EUROBIO SCIENTIFIC : Changement de nom adopté à l'Assemblée Générale Annuelle

Trillium Therapeutics Doses First Patient With TTI-622, Its Second Immune Checkpoint Inhibitor Targeting CD47

Elite Pharmaceuticals, Inc. Announces Passing of Board Member Eugene Pfeifer

FDA Clears Gold Standard Diagnostics’ Borrelia burgdorferi IgG/IgM ELISA Assay | Business Wire

Global Disposable Blood Bag Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 11% - ResearchAndMarkets.com | Business Wire

ExThera Medical gibt Abschluss von Studie zur Bewertung der Sicherheit des Blutfilters Seraph® 100 für die Registrierung der CE-Kennzeichnung bekannt | Business Wire

Akebia Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | Business Wire

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Previously Treated Patients with Recurrent or Metastatic Cervical Cancer Whose Tumors Express PD-L1 (CPS Greater Than or Equal to 1) | Business Wire

Los resultados del estudio fase III OPTIMISMM presentados en ASCO 2018 mostraron que el triplete PVd mejoraba la SLP en líneas precoces del mieloma múltiple recidivante o refractario | Business Wire

ExThera Medical annonce la conclusion de l'essai d'homologation du marquage CE visant à évaluer la sécurité d'emploi du filtre à sang Seraph® 100 | Business Wire

ContraVir Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record

リヴァノヴァの無縫合大動脈心臓弁パーシバルが日本で承認される | Business Wire

Agilent Enables CISH on Dako Omnis | Business Wire

Informations relatives au nombre total de droits de vote et d'actions

Riassunto: Pharnext presenterà i dati scientifici più aggiornati sui due suoi prodotti principali a diversi congressi scientifici internazionali | Business Wire

Los resultados de fase 2 de erdafitinib son prometedores para el tratamiento del cáncer urotelial metastásico | Business Wire

BRITVIC

Amarin Sponsors Three Scientific Presentations Scheduled for American Diabetes Association Scientific Sessions

Calithera to Present at the Jefferies and JMP Securities Healthcare Conferences in June

ESPERITE NV (ESP) LAUNCHS NEW AGAATA Dx, DIAGNOSTIC SYSTEM WITH MACHINE LEARNING CAPABILITIES FOR GENETIC CLINICAL LABORATORIES.